PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2010; 5(7): e11783.
Published online 2010 July 30. doi:  10.1371/journal.pone.0011783
PMCID: PMC2912770

Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model

Mark R. Cookson, Editor

Abstract

Background

Mutations in the gene encoding the E3 ubiquitin ligase parkin (PARK2) are responsible for the majority of autosomal recessive parkinsonism. Similarly to other knockout mouse models of PD-associated genes, parkin knockout mice do not show a substantial neuropathological or behavioral phenotype, while loss of parkin in Drosophila melanogaster leads to a severe phenotype, including reduced lifespan, apoptotic flight muscle degeneration and male sterility. In order to study the function of parkin in more detail and to address possible differences in its role in different species, we chose Danio rerio as a different vertebrate model system.

Methodology/Principal Findings

We first cloned zebrafish parkin to compare its biochemical and functional aspects with that of human parkin. By using an antisense knockdown strategy we generated a zebrafish model of parkin deficiency (knockdown efficiency between 50% and 60%) and found that the transient knockdown of parkin does not cause morphological or behavioral alterations. Specifically, we did not observe a loss of dopaminergic neurons in parkin-deficient zebrafish. In addition, we established transgenic zebrafish lines stably expressing parkin by using a Gal4/UAS-based bidirectional expression system. While parkin-deficient zebrafish are more vulnerable to proteotoxicity, increased parkin expression protected transgenic zebrafish from cell death induced by proteotoxic stress.

Conclusions/Significance

Similarly to human parkin, zebrafish parkin is a stress-responsive protein which protects cells from stress-induced cell death. Our transgenic zebrafish model is a novel tool to characterize the protective capacity of parkin in vivo.

Introduction

Parkinson's Disease (PD), the second most common neurodegenerative disease after Alzheimer's Disease, is characterized primarily by the progressive loss of dopaminergic neurons in the substantia nigra and subsequent dopamine depletion in the striatum. The etiopathogenesis of sporadic PD is only poorly understood, thus a milestone in PD research has been the identification of monogenic familial variants which account for up to 10% of PD cases. Mutations in the genes encoding α-synuclein and LRRK2 (leucine-rich repeat kinase 2) are responsible for autosomal dominant forms of PD, presumably by a gain-of-function mechanism. Loss-of-function mutations in the genes encoding parkin, PINK1, and DJ-1 mediate autosomal recessive PD. Sporadic and monogenic forms share important clinical, pathological and biochemical features, notably the progressive demise of dopaminergic neurons in the substantia nigra. Therefore, insight into the function and dysfunction of PD-associated gene products can help to elucidate the underlying mechanisms leading to neuronal cell death.

A large number and a wide spectrum of mutations in the parkin gene has been identified in PD patients, which account for the majority of early onset, autosomal recessive parkinsonism. The parkin gene encodes a cytosolic protein of 465 amino acids with a ubiquitin-like domain (UBL) at the N-terminus and a RBR (RING between RING) domain close to the C-terminus, consisting of two RING finger motifs which flank a cysteine-rich in-between RING finger domain. The presence of the RBR domain suggested that parkin has an E3 ubiquitin ligase activity, mediating the covalent attachment of ubiquitin to substrate proteins. A well known function of E3 ubiquitin ligases is to target substrate proteins for degradation by the proteasome. However, there is increasing experimental evidence that parkin can induce proteasome-independent ubiquitylation and that this mode of ubiquitylation may underlie the wide neuroprotective activity of parkin [1], [2], [3], [4], [5] To promote the understanding of the physiological function of parkin, great efforts have been made to establish animal models. Loss of parkin expression in mice accomplished by the deletion of exon 2, 3 or 7 did not recapitulate the typical characteristics of parkinsonism. Notably, only mild alterations in dopaminergic neurotransmission have been observed, but no degeneration of dopaminergic neurons, which might be explained by functional redundancy or compensatory mechanisms [6], [7], [8], [9]. In contrast to parkin knockout mice, Drosophila parkin null mutants show a marked phenotype, such as reduced lifespan, male infertility and locomotor defects caused by apoptotic muscle degeneration [10], [11], [12]. This discrepancy prompted us to investigate the role of parkin in another model organism. The zebrafish (Danio rerio) is emerging as a convenient vertebrate model to unravel the function of genes and to establish models for human diseases [13]. Considerable advantages are the external development of embryos and optical clarity during embryogenesis which facilitate the analysis of early developmental processes as well as disease progression. Furthermore, genetic manipulation, like a transient gene knockdown, can easily be performed by microinjection of antisense oligonucleotides at the single-cell-stage. To determine the impact of environmental influences, chemical compounds or toxins can be administered to the surrounding media.

In this study we analyzed the zebrafish orthologue of the human parkin gene using in vitro and in vivo approaches. We show that human and zebrafish parkin share key biochemical and functional features. Similarly to human parkin, zebrafish parkin shows auto-/transubiquitylation activity and is prone to misfolding and aggregation under high level stress conditions. Moreover, both human and zebrafish parkin are transcriptionally up-regulated in response to mild stress and can protect cells from stress-induced cell death. A transient knockdown of parkin in zebrafish revealed that parkin is not essential for its development. However, parkin deficiency increases the vulnerability of zebrafish to proteotoxic stress, while transgenic zebrafish stably overexpressing parkin are less sensitive to cell death induced by proteotoxicity.

Results

The parkin orthologue is highly conserved in zebrafish and expressed throughout development

BLAST search in the ENSEMBL zebrafish database using the human parkin protein sequence (NP_054642) led to the identification of one parkin orthologue in zebrafish (ENSDARG00000021555, zgc: 112390). The zebrafish parkin cDNA comprises an open reading frame of 1377 base pairs, encoding a 458 amino acid protein (Fig. 1A). The parkin protein is highly conserved between zebrafish and man; the overall identity is 62% with a significant increase in identity (up to 87%) in the functional domains (Fig. 1B). Reverse transcription PCR was used to analyze the expression profile of parkin. We detected parkin-specific transcripts during all stages of zebrafish development (Fig. 1C).

Figure 1
The zebrafish parkin orthologue is highly conserved and expressed during development.

Zebrafish parkin and human parkin share key biochemical features

A clone containing the zebrafish parkin cDNA was obtained from the Deutsches Ressourcenzentrum für Genomforschung (RZPD) and verified by sequencing. Despite the high level of identity, no anti-parkin antibody is available so far that crossreacts with zebrafish parkin. To circumvent this problem, the coding sequence of zebrafish parkin was subcloned into the pCMV Tag 2B vector (Stratagene), which allows the expression of N-terminally FLAG-tagged zebrafish parkin and subsequent detection with an anti-FLAG-antibody.

We first analyzed zebrafish parkin in cultured cells and focussed on biochemical and functional aspects of parkin. First, we tested whether zebrafish parkin has an E3 ubiquitin ligase activity. Since the discussion on authentic parkin substrates is still ongoing and controversial, we made use of the auto-/transubiquitylation activity observed for human parkin. HEK293T cells were co-transfected with HA-tagged ubiquitin and either FLAG-tagged human or zebrafish parkin. Immunoprecipitation under denaturing conditions was performed with anti-FLAG agarose beads, and precipitated proteins were subjected to a Western blot analysis using an anti-HA antibody. Similarly to human parkin, zebrafish parkin was able to promote its auto-/transubiquitylation (Fig. 2A).

Figure 2
Zebrafish parkin promotes auto-/transubiquitylation and is prone to misfolding in the presence of high level oxidative stress.

Previous work from our group and other laboratories indicated that parkin is prone to misfolding under high level stress conditions. The propensity to misfold is reflected by a shift of parkin from the detergent-soluble into the detergent-insoluble fraction and the appearance of aggregates [14]. To analyze whether zebrafish parkin shares the propensity to misfold under conditions of oxidative stress, SH-SY5Y cells transiently expressing zebrafish parkin were treated with hydrogen peroxide (10 mMol/L or 20 mMol/L for 30 min). After lysis in detergent buffer (0.1% Triton X-100 in PBS) followed by centrifugation two fractions (supernatant and pellet) were obtained. Whereas zebrafish parkin from untreated cells was primarily found in the detergent-soluble supernatant fraction, hydrogen peroxide induced a shift of zebrafish parkin from the soluble fraction into the detergent-insoluble pellet fraction in a dose-dependent manner (Fig. 2B). In addition to hydrogen peroxide, dopamine has been described to cause a conformational change of human parkin. Detergent-insoluble parkin covalently modified by an oxidation product of dopamine was found in dopamine-treated cultured cells as well as in the brains of PD patients [15]. To analyze the impact of this highly reactive catechol on zebrafish parkin, transiently transfected human SH-SY5Y cells were incubated in the presence of dopamine (0.5, 0.75, 1, or 2 mM for 5 h) and analzed by the detergent solubility assay as described above. Dopamine treatment induced the formation of detergent-insoluble high molecular weight zebrafish parkin aggregates (Fig. 2C). Aggregate formation of zebrafish parkin was also observed by indirect immunofluorescence of cells treated with dopamine (Fig. 3) or hydrogen peroxide (Fig. 4). Notably, human parkin and zebrafish parkin are able to co-aggregate under oxidative stress (Fig. 4).

Figure 3
Dopamine induces aggregation of zebrafish parkin.
Figure 4
Human and zebrafish parkin co-aggregate.

Zebrafish parkin is a stress-inducible and stress-protective protein

While parkin is inactivated under high level stress conditions, it has a remarkably wide neuroprotective activity under moderate stress conditions. Parkin has been shown to maintain neuronal integrity under various stressful conditions, including mitochondrial stress, excitotoxicity and ER stress [16], [17], [18]. In support of its crucial role in preventing stress-induced cell death, parkin gene expression is transcriptionally upregulated in response to cellular stress [3], [16], [18], [19], [20], [21], [22], [23], [24], [25], [26]. To analyze whether zebrafish parkin is also a stress-inducible protein, we made use of the zebrafish cell line Pac2, which was treated with rotenone, an inhibitor of complex I of the electron transport chain (10 nMol/L for 1 h). As no anti-parkin antibody is available to detect zebrafish parkin, we quantified endogenous parkin mRNA levels by real-time PCR 6 h after rotenone treatment. In comparison to non-treated control cells we observed a twofold increase in parkin mRNA levels in Pac2 cells exposed to rotenone (Fig. 5A). To test the activity of zebrafish parkin to reduce stress-induced cell death, SH-SY5Y cells transiently expressing human parkin or zebrafish parkin were exposed to the excitotoxin kainate (1 mMol/L for 3 h). Cells undergoing apoptosis were deteced by indirect immunofluorescence using an antibody against active caspase-3. Increased expression of both human and zebrafish parkin protected against the increase in apoptotic cells induced by excitotoxicity (Fig. 5B). Thus, similarly to human parkin, zebrafish parkin is not only a stress-responsive, but also a stress-protective protein.

Figure 5
Zebrafish parkin is stress-inducible and stress-protective.

Generation of a parkin-deficient zebrafish model

To gain more insight into the in vivo function of parkin, a transient knockdown in zebrafish was performed by making use of the antisense technology. Antisense gripNA™ targeting the exon-intron junction of exon 2 (parkin GT-grip) was microinjected into single-cell-stage zebrafish embryos (Fig. 6A). As a control, a mismatch oligonucleotide was injected. GT-grips are described to inhibit pre-mRNA splicing and allow quantification of gene knockdown without the use of antibodies [27]. As a consequence of blocking splice-donor sites three scenarios are possible: 1) the removal of the targeted exon, 2) the use of a cryptic splice donor site, often causing a premature termination codon, or 3) a retention of the targeted intron. To analyze the effects of the parkin GT-grip, total cellular RNA was isolated from zebrafish embryos one day after injection of the parkin GT-grip. Using reverse transcriptase PCR we could rule out the occurance of an alternative splice site. To answer the question whether the parkin GT-grip has an impact on splicing of exon 2 and/or intron 2, we performed semi-quantitative real-time PCR. A TaqMan™ probe was designed to target the exon2/exon3 junction (Fig. 6B). If exon 2 is spliced out and/or intron 2 is not removed the TaqMan™ probe cannot bind correctly and the subsequent decreased signal not only verifies the parkin knockdown, but also enables the quantification of its efficacy. Retention of intron 2 would result in a premature termination codon after codon 65. Loss of exon 2 would cause a frameshift with a premature termination after 4 codons. Due to the fact that exon 1 comprises only 7 base pairs, we were not able to discriminate between these two possibilities. Nevertheless, in either case the parkin protein is severely truncated to either 65 amino acids or 4 amino acids. Analysis of one-day-old zebrafish embryos confirmed splice interference upon parkin GT-grip injection and revealed an overall reduction of parkin mRNA by 53% in zebrafish microinjected with the parkin GT-grip compared to control-injected littermates (Fig. 6C). Notably, the parkin knockdown was stable over at least three days (Fig. 6C). However, we were not able to detect gross morphological or behavioral alterations in parkin knockdown zebrafish (Fig. 6D). Specifically, there were no obvious abnormalities in their swimming behavior and touch response (data not shown).

Figure 6
Transient knockdown of parkin in zebrafish does not lead to gross morphological alterations.

Parkin deficiency does not result in a loss of dopaminergic neurons

The teleostean homologue of the mammalian midbrain dopaminergic system is represented by dopaminergic neurons in the diencephalon [28]. Their spatial distribution is established by 72 hours post fertilization [29], [30], [31]. To test for a possible impact of parkin deficiency on dopaminergic neurons in the zebrafish brain, we used in situ hybridiziation of an antisense RNA probe for tyrosine hydroxylase (TH), which is the rate-limiting enzyme in the synthesis of dopamine. Parkin knockdown and control-injected zebrafish larvae were subjected to in situ hybridization 3 days post fertilization. Microscopic analysis of dopaminergic clusters provided ambiguous results. Interindividual variations in TH staining were not only observed in the parkin-deficient zebrafish cohorts, but also among control-injected larvae (Fig. 7A). We therefore chose an additional approach and determined TH mRNA levels in parkin-deficient zebrafish larvae by semi-quantitative real-time PCR in 5 independent experiments. We observed considerable variations in the TH mRNA levels from experiment to experiment, however, there was no correlation between the parkin knockdown efficiency and TH mRNA levels (Fig. 7B). To extend our analysis on possible effects of parkin deficiency on zebrafish dopaminergic neurons, we performed whole mount immunohistochemistry using an antibody against TH. Parkin knockdown and control-injected zebrafish larvae were stained at day 3 post fertilization. A three dimensional microscopic analysis of the stained dopaminergic clusters by a highly sensitive EMCCD camera revealed that the number of TH-positive neurons was not reduced in parkin-deficient zebrafish larvae, indicating that the partial downregulation of parkin (knockdown efficiency 55%) did not induce a loss of dopaminergic neurons in our zebrafish model. (Fig. 8A, B).

Figure 7
Parkin deficiency has no effect on tyrosine hydroxylase levels in zebrafish.
Figure 8
Parkin deficiency does not induce a loss of diencephalic dopaminergic neurons.

Downregulation of zebrafish parkin does not affect mitochondrial morphology or membrane potential

Many lines of evidence suggest that mitochondrial dysfunction plays an important role in the pathogenesis of PD [32], [33], [34], [35], [36], [37], [38]. In support of this notion, several PD-associated genes have an impact on mitochondrial integrity. In a previous study we could show that an acute downregulation of parkin in SH-SY5Y cells, primary mouse neurons and Drosophila S2 cells affects mitochondrial morphology, membrane potential and function [39]. To test whether a similar phenotype might occur in parkin-deficient zebrafish, we analyzed mitochondria in skin cells of parkin knockdown zebrafish in comparison to control-injected siblings one day post fertilization. Visualization of mitochondria was achieved by the injection of mRNA coding for mitochondrially targeted GFP at the one-cell-stage. Life cell imaging by fluorescence microscopy did not reveal alterations in mitochondrial morphology in epidermal cells of parkin-deficient zebrafish (Fig. 9A, upper images). Next we examined whether mitochondria from parkin knockdown zebrafish are more susceptible to fragmentation in response to rotenone treatment, as observed in cultured fibroblasts from patients with pathogenic homozygous or compound heterozygous parkin mutations [40]. We incubated dechorionated parkin-deficient and control zebrafish embryos with rotenone one day post fertilization (100 µg/l for 6 h). Rotenone-treated zebrafish embryos were characterized by shorter rod-like or spherical mitochondria, but there was no significant difference in mitochondrial fragmentation between control and parkin knockdown zebrafish embryos (Fig. 9A, lower images). Our imaging approach only allowed the assessment of mitochondria within the epidermis, which might be less sensitive to a loss of parkin function. We therefore performed a more comprehensive analysis of mitochondria by isolating total mitochondria from one-day-old parkin knockdown, control and wildtype zebrafish embryos. These mitochondria were analyzed for their membrane potential under basal conditions and in response to rotenone treatment (10 and 100 µM for 50 min) by measuring the uptake of the fluorescent carbocyanine dye JC-1. The ratio of JC-1 in its aggregated intra-mitochondrial form (orange fluorescence) to its monomeric cytoplasmic form (green fluorescence) was used as a quantitative index of mitochondrial function [41], [42]. Rotenone induced a decrease in the mitochondrial membrane potential in a dose-dependent manner, however, we could not detect significant differences between mitochondria isolated from parkin-deficient zebrafish, control-injected or wildtype zebrafish, neither under basal conditions nor in response to rotenone treatment (Fig. 9B).

Figure 9
Mitochondrial morphology and membrane potential is not affected in parkin-deficient zebrafish.

Generation and analysis of transgenic zebrafish stably expressing parkin

To investigate the neuroprotective capacity of parkin in an in vivo model, transgenic zebrafish lines stably expressing full-length human parkin were generated. We previously demonstrated that a Gal4/UAS-based bidirectional expression system in zebrafish allows efficient transgenesis, stable inheritance and expression of adequate protein levels combined with a facile identification of transgenic zebrafish due to concomitant expression of the fluorescent protein DsRed [43]. We cloned the Gal4-VP16 coding sequence under control of the ubiquitous promoter EF1α as a driver construct (Fig. 10A). The responder construct comprises the coding sequences of the fluorescent marker DsRed and full-length parkin under control of an upstream activating sequence (UAS). Consequently, the expression of Gal4-VP16 from the driver construct transactivates the UAS of the responder construct, leading to the concomitant transcription of DsRed and parkin. Transgenic zebrafish embryos could be distinguished from their non-transgenic siblings under fluorescent light due to the expression of DsRed (Fig. 10B). Parkin expression was detected by immunohistochemistry in cryosections of one-day-old embryos (Fig. 10C). Parkin was expressed in all tissues analyzed with high expression levels in the brain and eyes. A Western blot analysis revealed that parkin protein was expressed as early as 6 hours post fertilization (Fig. 10D).

Figure 10
Generation of transgenic parkin zebrafish.

Parkin protects zebrafish from apoptosis induced by proteotoxic stress

Based on our observation that parkin is able to protect cells from stress-induced cell death in cultured cells, we wondered whether the stress-protective capacity of parkin also applies to the zebrafish model. First, we quantified cell death in the spinal cord in parkin knockdown and transgenic zebrafish under physiological, non-stress conditions. Two-day-old parkin knockdown and parkin transgenic zebrafish embryos were treated with acridine orange in order to detect cell death in living fish. Acridine orange is a vital dye that is specifically taken up in damaged cells and stains nucleic acids in dying cells [44], [45]. Whereas the number of apoptotic cells occuring during normal zebrafish development was not altered in parkin transgenic zebrafish (Fig. 11B), parkin knockdown zebrafish showed a small but significant increase in the number of dying cells compared to control-injected zebrafish embryos (Fig. 11A). The difference in cell death rates between control knockdown zebrafish and control non-transgenic zebrafish is a consequence of the injection procedure, which is a common phenomenon. The slight increase in apoptotic cell death in parkin-deficient zebrafish embryos compared to control-injected embryos obviously causes no morphological or behavioral phenotype, but may indicate an increased general vulnerability of parkin-depleted cells. To follow up this idea, we subjected parkin-deficient and parkin-overexpressing zebrafish to proteotoxic stress. Heat shock is a classical inducer of proteotoxic stress by causing alterations in protein folding, leading to apoptotic cell death when a critical threshold has been exceeded [46]. It has been shown previously that heat shock induces proteotoxic stress also in zebrafish. A temporary elevation of the surrounding temperature by 11°C (from 28°C to 39°C) results in extensive apoptosis in zebrafish embryos throughout the body, particularly in sensitive regions of the brain and spinal cord [47]. Two-day-old parkin knockdown and control-injected zebrafish embryos were exposed to an heat shock by incubating them at 39°C for 1 h followed by a recovery at 28°C for 8 h. Of note, these conditions did not have an effect on the viability, morphology or behavior of zebrafish embryos (data not shown). After a recovery at 28°C for 8 h, the zebrafish embryos were treated with acridine orange, and dying cells were quantified by a microscopic analysis, which revealed a significant increase of cell death in the whole spinal cord of parkin-deficient embryos (Fig. 11C). Next, we performed the same analysis with parkin transgenic zebrafish. Accordingly, two-day-old parkin transgenic zebrafish embryos and their non-transgenic siblings were heat shocked and analyzed as described above. In parkin transgenic zebrafish the number of dying cells upon heat shock was significantly reduced in comparison to non-transgenic siblings (Fig. 11D). Notably, the heat shock conditions applied in our zebrafish model did not cause misfolding of parkin, as determined by a detergent solubility assay (Fig. 11E). Based on the fact that zebrafish live at an ambient temperature of 28°C, an increase to 39°C caused a thermal stress in this organism whithout inducing a conformational change of parkin. In conclusion, parkin-deficient zebrafish are more vulnerable to stress-induced cell death, while parkin transgenic zebrafish are more resistant to cellular stress.

Figure 11
Parkin protects zebrafish from heat shock-induced cell death.

Discussion

In this study, we made use of the vertebrate Danio rerio as an additional vertebrate model organism to study the function of parkin. The zebrafish parkin orthologue is highly homologous to human parkin, particularly within the functional domains and is expressed at all developmental stages up to adulthood. Moreover, zebrafish parkin shows the same biochemical and functional features as human parkin: It is transcriptionally up-regulated in response to cellular stress and protects from stress-induced cell death. We and others have previously shown that human parkin is stress-inducible and stress-protective under moderate stress conditions, while severe oxidative stress induces misfolding and aggreagtion of parkin, leading to its inactivation [14], [15], [48]. In line with these findings, zebrafish parkin adopts a detergent-insoluble conformation and forms cellular aggregates in cells treated with hydrogen peroxide or dopamine.

To study the consequences of parkin deficiency in zebrafish, we used the antisense knockdown technology. The injection of an antisense oligonucleotide targeting the exon-intron junction of exon 2 resulted in a frame shift generating a premature termination codon. The knockdown efficiency determined by semi-quantitative real-time PCR of the normal zebrafish parkin mRNA was between 50 and 60% from day 1 until day 3 after injection, however, we could not detect significant morphological or behavioral alterations in parkin-deficient zebrafish. Specifically, we did not observe a significant loss in diencephalic dopaminergic neurons, neither by in situ hybridization with an antisense RNA probe for tyrosine hydroxylase (TH) nor by whole mount immunohistochemistry using an anti-TH antibody. Of note, we observed large interindividual variations in the TH mRNA levels both in the control and parkin-deficient cohorts, but there was clearly no correlation between the efficiency of parkin knockdown and the levels of TH. In line with our findings, degeneration of nigrostriatal dopaminergic neurons could not be found in different parkin knockout mouse strains with a targeted deletion of exon 2, 3 or 7 [6], [8], [9], [49]. Inactivation of parkin in Drosophila melanogaster provided controversial results. While Greene et al., Pesah et al. and Saini et al. no did not observe neuronal loss in the dorsomedial, dorsolateral, or anteromedial clusters, Whitworth et al. found a significant reduction of dopaminergic neurons in the protocerebral posterior lateral cluster of parkin-deficient flies [10], [50], [51], [52]. In a different parkin null Drosophila model, a reduction of TH immunostaining and shrunken morphology has been observed in dorsomedial dopaminergic neurons [53]. In contrast to our data, a 20% decrease in diencephalic TH-positive cells has recently been reported in another zebrafish model of parkin deficiency [54]. One explanation for this discrepancy could be differences in the knockdown approach. Flinn et al. used a morpholino antisense oligonucleotide targeting exon 9, resulting in a 51 amino acid deletion within the IBR (in between RING) domain. We observed that deletions within the RBR domain, including RING1, IBR and RING2, induce the formation of misfolded, aggregated parkin (unpublished data). Thus, it cannot be excluded that the resulting mutant parkin protein lacking the IBR domain has some toxic potential due to its misfolded state. In support of such a scenario, Flinn et al. observed electron dense material in the t-tubules of fast muscle cells in the trunk somites of their parkin knockdown zebrafish larvae. Another explanation would be differences in the efficiency and duration of the parkin knockdown. As the antisense approach allows only a transient and early downregulation of parkin during the first days of development, we cannot exclude that parkin deficiency at later stages could lead to phenotypic alterations. A knockdown effciency between 50 and 60% models the heterozygous carrier state of parkin mutations rather than the complete loss of function usually found in parkin-associated parkinsonism. It would therefore be interesting to establish stable parkin knockout zebrafish lines by TILLING approaches or by targeted gene mutagenesis using zink finger nucleases [55], [56], [57].

Although our parkin-deficient zebrafish did not display obvious morphological alterations, they were characterized by an increased vulnerability to stress-induced cell death. This observation is in line with the notion that parkin has a neuroprotective activity under cellular stress. In fact, the wide neuroprotective capacity of parkin is the most consistent and reproducible activity of parkin, which correlates best with the the loss-of-function phenotype of pathogenic mutants [32]. Parkin protects cultured cells from cell death induced by excitotoxins, mitochondrial toxins and various other stressors [3], [16], [18], [21], [22], [23], [24], [25], [26]. To better characterize the neuroprotective activity of parkin in an animal model, we generated transgenic zebrafish stably overexpressing parkin. By making use of the Gal4/UAS-based bidirectional expression system we described previously [43], parkin was ubiquitously and stably expressed in transgenic zebrafish as early as 6 hours post fertilization up to adulthood. To establish an appropriate stress model in zebrafish, we tested various toxins, such as mitochondrial toxins (rotenone, CCCP) and excitotoxins (L-glutamic acid, kainate). Unfortunately, the effects of these toxins were difficult to titrate in zebrafish: lower concentrations had no significant effect on cell viability, while at higher concentrations no zebrafish survived. We therefore used thermal stress as a paradigm for proteotoxic stress, which has been decribed to cause apoptosis in zebrafish embryos, particularly in the brain and spinal cord [47]. In response to a transient heat shock, significantly more dying cells were detected in parkin-deficient zebrafish embryos in comparison to littermate controls. Transgenic expression of parkin protected against cell death induced by thermal stress, proving the stress-protective capacity of parkin in vivo. It will now be interesting to use the transgenic parkin zebrafish model for a further characterization of the protective capacity of parkin, for example by cross-breeding transgenic parkin zebrafish with other genetic PD zebrafish models.

Materials and Methods

DNA constructs

The following clone containing zebrafish parkin was ordered from the RZPD (Deutsches Ressourcenzentrum für Genomforschung): RZPD clone ID: IMAGp998G2015580Q1. The zebrafish parkin coding sequence was subcloned into pCMV Tag 2B vector (Stratagene, La Jolla, USA), allowing the expression of N-terminally FLAG-tagged zebrafish parkin (FLAG-zf-parkin). For the expression of FLAG-tagged human parkin, the coding sequence of human parkin was cloned into the pCMV Tag 2B vector (FLAG-hu-parkin). The HA-ubiquitin construct has been described before [3].

Antibodies and reagents

The following antibodies were used: anti-ACTIVE caspase-3 pAb (Promega, Mannheim, Germany), cyanine 3 (Cy3)-conjugated anti-rabbit IgG (Dianova, Hamburg, Germany), anti-β-actin mAb (AC-74; Sigma, Taufkirchen, Germany), horseradish peroxidase (HRP)-conjugated anti-mouse and anti-rabbit IgG antibody (Amersham Biosciences, Foster City, CA), anti-HA pAb H6908, anti-FLAG M2 mAb F3165 and anti-FLAG M2 affinity gel, (Sigma), anti-parkin PRK8 mAB (Abcam, Cambridge, USA), anti-GAPDH mAb (AM 4300; Ambion, Austin, USA), anti-HA mAb HRP 3F10 (Roche, Mannheim, Germany), anti-TH pAb (Immunostar, Hudson, USA), AlexaFluor™488 goat anti-mouse IgG, AlexaFluor™488 goat anti-rabbit IgG and AlexaFluor™555 goat anti-mouse IgG (Invitrogen, Karlsruhe, Germany). Rotenone and dopamine, N-ethylmaleamide and JC-1 (5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolcarbocyanine iodide) were purchased from Sigma, kainate from Calbiochem (Darmstadt, Germany), hydrogen peroxide and MG-132 from Merck (Darmstadt, Germany), DAPI (4′–6′-diamidino-2-phenylindole) from Invitrogen, and complete protease inhibitor cocktail from Roche.

Cell culture and transfection

Human embryonic kidney cells (HEK293T), human neuroblastoma cells (SH-SY5Y) and HeLa cells were cultivated as described previously [14], [58]. The zebrafish embryonic fibroblast cell line Pac2 (Dekens MPS, Current Biology, 2003) were kept in L15 Medium (Leibovitz) from Invitrogen with 15% FCS,100 U/mL penicillin and 100 mg/mL streptomycin. Cells were transfected by a liposome-mediated method using Lipofectamine Plus Reagent (Invitrogen) according to the manufacturer's instructions.

Western Blotting

Proteins were size-fractionated by SDS-PAGE (10% polyacrylamide) and transferred to nitrocellulose (Protran BA 85, Schleicher & Schuell, Dassel, Germany) by electroblotting. The nitrocellulose membranes were blocked with 5% nonfat dry milk in PBST (PBS containing 0.1% Tween 20) for 30 min at room temperature and subsequently incubated with the primary antibody diluted in PBST for 16 h at 4°C. After extensive washing with PBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 40 min at room temperature. Following washing with PBST, the antigen signal was detected with the enhanced chemiluminescence detection system (Amersham Biosciences) as specified by the manufacturer.

Ubiquitylation assay

HEK293T were transiently co-transfected with HA-tagged ubiquitin and either pCMV Tag2B vector, pCMV Tag2B human parkin (FLAG-hu-parkin) or pCMV Tag2B zebrafish parkin (FLAG-zf-parkin). The cells were incubated with 5 µM MG-132 over night. One day after transfection, protein extracts were prepared in denaturing lysis buffer (50 mM Tris/HCl, pH 7.4, 5 mM EDTA, 1% SDS, 15 U/ml DNase I, protease inhibitor cocktail and 25 mM N-ethylmaleamide) and boiled for 5 minutes. Protein extracts were diluted 1[ratio]10 with non-denaturing lysis buffer (50 mM Tris/HCL pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail). After incubation on ice followed by centrifugation the supernatant was pre-cleared by shaking with agarose beads at 4°C for 1 h. Aliquots from the supernatant were taken as an input control, the rest was incubated with anti-FLAG M2 agarose beads overnight in order to pull down FLAG-zf-parkin and FLAG-hu-parkin. After washing three times with non-denaturing lysis buffer and TBS the proteins present in the immunoprecipitates were released from the FLAG-M2 agarose beads by addition of Laemmli sample buffer containing 1% SDS and heating at 95°C for 5 min. Proteins present in the immunoprecipitates were analyzed by Western blotting using the anti-HA mAb HRP 3F10.

Caspase-3 Assay

SH-SY5Y cells were grown on glass coverslips and co-transfected with EYFP and either vector, human FLAG-parkin or zebrafish FLAG-parkin. 24 h after co-transfection, cells were treated with kainic acid (1 mM) for 3 h. Subsequently, cells were fixed with 4% paraformaldehyde for 30 min, permeabilized with 0.2% Triton X-100 for 10 min at room temperature, and blocked with 5% BSA, 0.1% Tween 20 in PBS for 1 h at room temperature. Fixed cells were incubated with anti-ACTIVE caspase-3 antibody overnight at 4°C, followed by an incubation with Cy3-conjugated secondary antibody for 1 h at room temperature. After washing with PBS cells were mounted onto glass slides and examined by fluorescence microscopy using a Zeiss (Jena, Germany) Axioscope2 plus microscope. To detect cells undergoing apoptosis, the number of activated caspase-3 positive cells of a minimum of 300 transfected cells was determined. Quantifications were based on duplicates of at least three independent experiments.

Indirect immunofluorescence experiments

SH-SY5Y or HeLa cells were grown on glass coverslips. 24 h after transfection with FLAG-zf-parkin cells were incubated in 5 mM rotenone for 5 h. Afterwards the cells were fixed in 50% aceton/50% methanol for 1 min at room temperature and blocked with 1% BSA in TBS for 2 h at room temperature. Fixed cells were incubated with anti-FLAG M2 mAb and/or anti-HA pAb overnight at 4°C, followed by an incubation with AlexaFluor™ goat anti-mouse IgG and/or AlexaFluor™ goat anti-rabbit IgG for 2 h at room temperature. After washing with TBS, cells were mounted onto glass slides and examined by fluorescence microscopy using a Zeis Axioscope2 plus microscope. Nuclei were stained with 4′, 6′-diamidino-2-phenylindole (DAPI).

Semi-quantitative real-time PCR

Pac2 cells were incubated with 10 nM rotenone for 1 h and harvested 6 h after drug treatment. Total cellular RNA was isolated and samples were treated with DNase I according to the instructions of the manufacturer (RNeasy mini kit; Qiagen, Hilden, Germany). Zebrafish embryos and larvae were frozen in liquid nitrogen at 1, 2 or 3 days post fertilization. 10–20 embryos or larvae, respectively, were lysed in 1 ml lysis buffer containing 10 µl β-mercaptoethanol and homogenized by passing through a needle. After high speed centrifugation the supernatant was mixed 1[ratio]1 with 70% ethanol. The following centrifugation, DNase digestion and washing steps on the RNeasy mini column were performed according to the manufacturer's instruction. cDNA was synthesized using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Each semi-quantitative real-time PCR sample (20 µl) included 9 µl of cDNA solution, 10 µl of 2x TaqMan™ Universal PCR Master Mix, and 1 µl working stock of TaqMan Gene Expression Assay containing zf-Parkin-E23F (forward): ACGAGAGCTCTGCAATGAATCC, zf-Parkin-E23R (reverse): ACATGAACCGTGCTCTGCTC, zf-Parkin-E23M (TaqMan™ probe): ATCACAGCCCTGAAGTGT; zf-b-actin1-E45F (forward): GCTCTCTCCAGCCTTCCTT, zf-b-actin1-E45R (reverse): TCGCACTTCATGATGGAGTTGA, zf-b-actin1-M45 (TaqMan probe): CTGGGTATGGAATCTT; zf-tyrosine hydroxylase-E56F: GGAGAACCAATTCCTAGAGTGGACTA, zf-tyrosine hydroxylase-E56R (reverse): GATCTCGGAGGGTGGAGTAGA, zf-tyrosine hydroxylase-E56M (TaqMan™ probe): CCTCCCGCCATGTTC. Quantification was performed with 7500 Fast Real Time System (Applied Biosystems) using triplicates for each primer set and each RNA sample. RNA expression was normalized with respect to zf-β-actin. Relative expression was calculated for each gene using the DDCt method.

Stress treatment and detergent solubility assay

24 h after transfection SH-SY5Y cells were incubated in PBS containing 10 or 20 mM H2O2 for 30 min or 0.5, 0.75, 1, 2, or 5 mM dopamine for 5 h. Cells were washed twice with cold PBS, scraped off the plate, pelleted by centrifugation, and lysed in cold detergent buffer (0.1% Triton X-100 in PBS). The lysate was centrifuged at 15,000× g for 20 min at 4°C. The supernatant fraction was then separated from the pellet fraction. After adding Laemmli sample buffer to both fractions the samples were boiled for 10 min. To compare the relative distribution of zebrafish parkin, equal amounts of the detergent-soluble and -insoluble fractions obtained from untreated or stressed cells were analyzed by immunoblotting. To analyze the detergen solubility of parkin in heat shocked zebrafish, transgenic parkin zebrafish and their non-transgenic siblings were heat shocked 48 h post as described below. The zebrafish were allowed to recover at 28°C for 4 h, 8 h and 12 h. Cohorts of 20 embryos were lysed in detergent buffer (0.2% Triton X-100 in PBS containing complete protease inhibitor cocktail [Roche, Mannheim, Germany; diluted 1[ratio]100] and passed thirty times through a 27-gauge needle. After centrifugation at 15,000× g at 4°C for 20 min the supernatant was separated from the pellet and further processed as described above.

Zebrafish Maintenance and Breeding

Zebrafish were maintained, mated, and raised as described [59]. Embryos were kept in embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) at 28°C and staged as previously shown [60]. The wildtype line AB, TLF and albino were used for all experiment (www.zfin.org).

Antisense gripNAs™-mediated knockdown of parkin

Sequence-specific antisense oligonucleotides of 18 nucleotides in length (gripNAs™) were obtained from Activ motif (Carlsbad, USA). For parkin we used a grip hybridizing to a splice-donor-site of an exon-intron junction, resulting in a nonsense splicing product (GT-grip). As control a mismatch GT-grip was designed. Zf-Parkin-GT2-grip: TTACCTGAAGTGTGGATT. Zebrafish embryos were microinjected with a Femto Jet Microinjector (Eppendorf, Hamburg, Germany) at the one-cell-stage with 13 ng gripNA™. After injection the zebrafish embryos were maintained in embryo medium at 28°C.

Transgenic parkin zebrafish

To generate transgenic zebrafish expressing DsRed and human parkin, the full-length human parkin cDNAwas amplified from a pCS2+ vector (Rupp RA, Genes Dev., 1994) by PCR using primers hP-XbaI-F: 5′-GCTCTAGAGCCACCATGATAGTGTTTGTCAG-3′ and d179-XbaI-R: 5′-TGCTCTAGACTACACGTCGAACCAGTGGTCCC-3′. The amplicon was cloned into the PCR8/GW/TOPO/Entry vector (Invitrogen). The insert of the entry vector was subcloned into the destination responder vector by LR-recombination using the gateway recombination system in order to obtain a protein expression vector [43]. EF1α-Gal4-VP16 was amplified by PCR from pBEF1α-Gal4-VP16 (kindly provided by R. W. Köster) using the primers MI3-FP: TGTAAAACGACGGCCAGT and MI3-RP: CAGGAAACAGCTATGACC and TOPO-cloned into pCR8/GW-ENTR/TOPO. Then, EF1α-Gal4-VP16 was transfered into pT2d-DEST-GwRI-R2 by LR-recombination. The resulting plasmid pT2d-EXP- EF1α-Gal4-VP16.pA was used to generate transgenic zebrafish. All the further experimental steps including the transformation of E.coli DH5alpha were done according to the instructions of the Gateway Clonase LR II enzyme kit (Invitrogen). Plasmid DNA was prepared and purified for injection into zebrafish embryos using the Geneclean II Kit (Qbiogene, Carlsbad, USA). In order to obtain transposase mRNA, plasmid DNA was linearized and purified by phenol/chloroform extraction. mRNA was synthesized using the Ambion mMESSAGE mMachine Kit (Applied Biosystems) according to the manufacturer's protocol. Shortly before the injection, purified DNA constructs were diluted with DEPC (diethylenepyrocarbonate)-treated ultrapure water to an approximate concentration of 15 ng/µl for the driver construct and 40 ng/µl for the responder construct. In parallel, transposase mRNA was diluted to 20 ng/µl in DEPC water. DNA and mRNA dilutions were mixed in a 1[ratio]1 ratio and phenol red was added to a final concentration of 20% (v/v). One-cell-stage fertilized zebrafish eggs were injected with about 1 nl of the injection mixture. Expression of transposase after mRNA injection catalyzes the integration of both the driver and responder construct into the zebrafish genome via the Tol2 sites [61]. Injected embryos were screened for DsRed expression between 24 to 48 hours after fertilization using fluorescence microscopy. Zebrafish embryos positive for DsRed expression and with a normal appearance were sorted and further raised to adulthood. Adult founder zebrafish were identified by outcrossing them to AB/Albino/TLF fish (generously provided by L. Bally-Cuif) and screening the F1 generation for DsRed-expressing embryos. These embryos were raised to establish stable transgenic lines.

Cryosection and immunostainings of zebrafish embryos

For immunostaining of parkin, zebrafish embryos were fixed in 4% paraformaldehyde overnight. After short washing in PBS single fish were embedded in Tissue-Tek OCT compound (Sakura Finetek Europe, Zoeterwoude, The Netherlands) and frozen on dry ice. 14 µm thin sections were cut on a Microm HM 560 cryotome (Thermo Scientific, Walldorf, Germany) at −22°C and collected on microscopic slides. Embedding medium was removed by washing the slides with PBS containing 0.5% Tween-20. The slides were blocked in 10% NCST in PBST (10% newborn calf serum, 0.1% Tween and 1% DMSO in PBS) for two hours, then the anti-parkin mAb PRK8 was diluted 1[ratio]200 in 2% NCST and incubated overnight at 4°C. After incubation with anti-mouse Alexa-488 antibody for three hours at room temperature the slices were washed in PBST and PBS. Mowiol mounting medium (Calbiochem) was homogenously distributed and the slices were covered with coverslips. The sections were analyzed using a Zeiss Axioscope2 plus microscope. For immunostaining of TH, 3-day-old zebrafish were fixed overnight in 4%PFA, transfered to methanol, rehydrated in PBST, transfered to distilled water, incubated in icecold aceton for 7 min at −20°C, blocked with NCST and incubated with the anti-TH antibody diluted in NCST (1[ratio]200) overnight. The first antibody was detected with an anti-mouse-Alexa-488 antibody overnight. Larvae were transfered to 75% glycerol in distilled water, mounted in 50% glycerol/1% agarose in distilled water and analyzed by microscopy.

Imaging of dopaminergic neurons in zebrafish larvae

Three-day-old larvae stained with an anti-TH antibody (Immunostar, Hudson, USA) were analyzed using a Zeiss Cell Observer Spinning Disc microscope. Images were taken using a Zeiss LD LCI Plan-Apochromat 25x/0.80 objective with glycerol immersion and a Photometrics Evolve 512 EMCCD camera. In parallel, larvae from the same injected clutch were subjected to quantitative real time PCR in order to determine the parkin knockdown efficiency. Dopaminergic neurons of populations 1 to 6 in the posterior tuberculum (according to terminology developed by Rink and Wullimann [62] were counted in parkin GT-grip-injected embryos and mismatch GT-grip-injected embryos in a blinded manner, i.e. the researcher was blind to the knockdown status. These dopaminergic neurons include the populations ascending to the striatum (populations 1, 2 and 4). As these neurons lie in different layers of the brain, a Z-stack of the brain was taken, which contained all neurons of these populations. A 3D image was projected and depth-color coded using the Zeiss Axiovision software. The depth coloring allows to discriminate neurons lying perpendicular on top of each other.

Heat shock

Cohorts of 20 zebrafish embryos were put into a volume of 1 ml embryo medium in 2 ml Eppendorf cups. Cups with open lids were placed in a heating block at 39°C for 1 h. Stress treatment was administered 48 h post fertilization and embryos were allowed to recover at 28°C for 4, 8 and 12 h, respectively.

In situ hybridization

5 µg of pB-SK zTH (kindly provided by W. Driever) were linearized with XhoI at 37°C overnight and cleaned up using phenol/chloroform. 1 µg of purified DNA was subjected to Digoxigenin-RNA synthesis following the manufacturer's instruction (DIG RNA Labeling Kit, Roche) and T3 RNA polymerase (Fermentas, St. Leon-Rot, Germany). After precipitation the pellet was resuspended in DEPC-treated ultrapure water, 20× SSC (standard saline citrate) and formamide. Zebrafish larvae were fixed in 4% paraformaldehyde (PFA) overnight at 4°C 3 days post fertilization. They were washed twice in PBST for 5 min at room temperature. After digestion with proteinase K in PBST (10 µg/ml) (Roche) for 20 min larvae were postfixed in 4% PFA for 20 min at room temperature and then washed twice in PBST for 5 min at room temperature. Larvae were pre-hybridized in hybridization buffer (50% formamide, 5× SSC, 0.1% Tween, 50 µg/ml heparin, 5 mg/ml torula yeast RNA) at 65°C for 2 h. Hybridization was carried out overnight at 65°C in hybridization buffer containing tyrosine hydroxylase single-stranded RNA probe labeled with digoxigenin-UTP (Roche). All subsequent washing steps were carried out at 65°C. Washes were performed as follows: 2×30 min in 50% formamide, 2 x SSCT (standard saline critrate +0.1% Tween); 1×15 min in 2× SSCT; 2×30 min in 0.2× SSCT; 1×10 min in 66% 0.2× SSCT, 33% PBST; 1×10 min in 33% SSCT, 66% PBST, 1×10 min in PBST. Larvae were blocked for 1 h at room temperature in blocking buffer (10% fetal calf serum, 1% DMSO, 0.1% Tween 20 in PBS) and subsequently shaken overnight at 4°C in pre-absorbed Fab-alkaline phosphatase (Roche) in blocking buffer (1[ratio]4000). Larvae were washed three times in staining buffer for 10 min at room temperature. To reduce endogenous phosphatase activity, 0.25 mg/ml levamisole (Sigma) was added to the staining buffer (100 mM Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween 20). Staining was carried out with nitroblue tetrazolium chloride (NBT) (Sigma) and 5-bromo 4-chloro3indolyl phosphate (BCIP) (Roche) in staining buffer for 30 min. Pictures were taken using a Zeiss compound microscope with a Zeiss Plan-Apochromat 10×/0.45 lens. Z-stack images were generated by scanning through the brain at an optimal image slice distance and combined in a maximum projection.

Acridine orange staining

2 days post fertilization zebrafish embryos were dechorionated, anesthetized with tricaine (Sigma) and incubated alive in 9 µg/ml acridine orange (Sigma) in embryo medium for 30 min at room temperature. Stained embryos were analyzed after 3 wash steps of 5 min with embryo medium. For imaging, zebrafish embryos were embedded in 1.5% low melting agarose and overlayed with embryo medium containing tricaine. The neurons with fluorescent green nuclei undergoing cell death were counted in the whole spinal cord using a Zeiss compound microscope with a Zeiss Plan-Apochromat 10×/0.45 lens. Counting of 30 to 70 embryo of each group was performed in a blinded manner.

Live imaging of mitochondria in zebrafish

Embryos were microinjected at the one-cell-stage with gripNA™, mRNA coding for GFP containing a mitochondrial targeting sequence (mito-GFP, which was synthesized from pCS2+mito-GFP after subcloning from pYX223mtGFP [63]). For some experiments we additionally microinjected the mRNA of the histone protein H2B containing the coding sequence of the monomeric red fluorescent protein, in order to stain cell nuclei. One day post fertilization dechorionated embryos were incubated with rotenone (100 µg/L for 6 h). For imaging, anesthetized zebrafish embryos were embedded in 1.5% low melting agarose and overlayed with embryo medium containing tricaine. Pictures were taken using a Zeiss LSM Meta Confocal microscope.

Isolation of mitochondria from zebrafish

Crude mitochondrial and cytoplasmic fractions were isolated using a Mitoiso 1 isolation kit (Sigma). All steps were performed at 4°C with icecold buffers. 24 hours post fertilization 30 embryos were dechorionated, anesthetized and homogenated in the supplied extraction buffer by sonication. Homogenates were spun at 600× g for 5 min at 4°C, and then the supernatants were spun at 11,000× g for 10 min at 4°C. The resulting pellet was resupended in extraction buffer and the centrifugation steps were repeated. The final pellets representing the mitochondrial fraction were resuspended in the supplied storage buffer.

Measurement of the mitochondrial membrane potential

The mitochondria fractions were either left untreated or were incubated with the mitochondrial complex I inhibitor rotenone (10 µM or 100 µM) for 10 min at room temperature. The integrity of the mitochondrial membrane potential was assessed by measuring the uptake of fluorescent dye 5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). The mitochondria fractions were incubated with the supplied JC-1 Assay buffer (Sigma) and JC-1 for 10 min at room temperature following the manufacturer's instruction. The fluorescence was detected using a Fluoroskan Ascent plate reader (Sigma): excitation 485 nm/emission 538 nm for green fluorescence of monomeric cytosolic JC-1 and excitation 530 nm/emission 590 nm for orange fluorescence of intramitochondrial JC-1 aggregates. The ratio of 590/538 nm (orange/green) was considered as an indicator of mitochondrial membrane potential. Quantifications were based on triplicates of three independent experiments.

Ethics Statement

All zebrafish husbandry and experimental procedures were performed in accordance with the German animal protection standards and were approved by the Government of Upper Bavaria (Regierung von Oberbayern, Munich, Germany).

Statistical analysis

Mean values and standard deviations (SD) were calculated with Microsoft Excel. Statistical analysis was performed using 2-tailed Student's t test, *p<0.05, **p<0.01, ***p<0.001. Data are presented as mean ± SD.

Acknowledgments

AB/Albino/TLF zebrafish were generously provided by Laure Bally-Cuif, Pac2 cells were a kind gift of Nicholas S. Foulkes, the pB-SK zTH vector was kindly provided by Wolfgang Driever and Jochen Holzschuh and the pBEF1α-Gal4-VP16 vector by Reinhard W. Köster. We thank Alexander Hruscha, Mathias Teucke, Alexandra Deinlein, Veronika Müller, Kerstin Lämmermann and Katharina Biersack for excellent technical assistance.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by the Deutsche Forschungsgemeinschaft (SFB 596: Molecular Mechanisms of Neurodegeneration), the German Ministry for Education and Research (NGFN plus: Functional Genomics of Parkinson's Disease), and the Helmholtz Alliance Mental Health in an Ageing Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Fallon L, Belanger CM, Corera AT, Kontogiannea M, Regan-Klapisz E, et al. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol. 2006;8:834–842. [PubMed]
2. Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum Mol Genet. 2006;15:2059–2075. [PubMed]
3. Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, et al. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci. 2007;27:1868–1878. [PubMed]
4. Lim KL, Dawson VL, Dawson TM. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol Aging. 2006;27:524–529. [PubMed]
5. Moore DJ, West AB, Dikeman DA, Dawson VL, Dawson TM. Parkin mediates the degradation-independent ubiquitination of Hsp70. J Neurochem. 2008;105:1806–1819. [PubMed]
6. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003;278:43628–43635. [PubMed]
7. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279:18614–18622. [PubMed]
8. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet. 2003;12:2277–2291. [PubMed]
9. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, et al. Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U S A. 2004;101:10744–10749. [PubMed]
10. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003;100:4078–4083. [PubMed]
11. Park J, Lee SB, Lee S, Kim Y, Song S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006;441:1157–1161. [PubMed]
12. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441:1162–1166. [PubMed]
13. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–367. [PubMed]
14. Winklhofer KF, Henn IH, Kay-Jackson PC, Heller U, Tatzelt J. Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. J Biol Chem. 2003;278:47199–47208. [PubMed]
15. LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. Dopamine covalently modifies and functionally inactivates parkin. Nat Med. 2005;11:1214–1221. [PubMed]
16. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet. 2003;12:517–526. [PubMed]
17. Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem. 2000;275:35661–35664. [PubMed]
18. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, et al. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron. 2003;37:735–749. [PubMed]
19. Tan EK, Puong KY, Chan DK, Yew K, Fook-Chong S, et al. Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association. Hum Genet. 2005;118:484–488. [PubMed]
20. Wang HQ, Imai Y, Kataoka A, Takahashi R. Cell type-specific upregulation of Parkin in response to ER stress. Antioxid Redox Signal. 2007;9:533–542. [PubMed]
21. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron. 2002;36:1007–1019. [PubMed]
22. Muqit MM, Moss J, Sewry C, Lane RJ. Phenotypic variability in siblings with type III spinal muscular atrophy. J Neurol Neurosurg Psychiatry. 2004;75:1762–1764. [PMC free article] [PubMed]
23. Higashi Y, Asanuma M, Miyazaki I, Hattori N, Mizuno Y, et al. Parkin attenuates manganese-induced dopaminergic cell death. J Neurochem. 2004;89:1490–1497. [PubMed]
24. Jiang H, Ren Y, Zhao J, Feng J. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004;13:1745–1754. [PubMed]
25. Hyun DH, Lee M, Halliwell B, Jenner P. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults. J Neurosci Res. 2005;82:232–244. [PubMed]
26. Rosen KM, Veereshwarayya V, Moussa CE, Fu Q, Goldberg MS, et al. Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem. 2006;281:12809–12816. [PubMed]
27. Draper BW, Morcos PA, Kimmel CB. Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown. Genesis. 2001;30:154–156. [PubMed]
28. Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, et al. Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish. 2006;3:235–247. [PubMed]
29. Lam CS, Korzh V, Strahle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci. 2005;21:1758–1762. [PubMed]
30. Rink E, Wullimann MF. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 2001;889:316–330. [PubMed]
31. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, et al. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res. 2005;141:128–137. [PubMed]
32. Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta. 2010;1802:29–44. [PubMed]
33. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008;7:97–109. [PubMed]
34. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci. 2006;7:207–219. [PubMed]
35. Vila M, Ramonet D, Perier C. Mitochondrial alterations in Parkinson's disease: new clues. J Neurochem. 2008;107:317–328. [PubMed]
36. Bueler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol. 2009;218:235–246. [PubMed]
37. Bogaerts V, Nuytemans K, Reumers J, Pals P, Engelborghs S, et al. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum Mutat. 2008;29:832–840. [PubMed]
38. Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci. 2007;120:1707–1716. [PubMed]
39. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem. 2009;284:22938–22951. [PMC free article] [PubMed]
40. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64:555–565. [PMC free article] [PubMed]
41. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry. 1991;30:4480–4486. [PubMed]
42. Anichtchik O, Diekmann H, Fleming A, Roach A, Goldsmith P, et al. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci. 2008;28:8199–8207. [PubMed]
43. Paquet D, Bhat R, Sydow A, Mandelkow EM, Berg S, et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 2009 [PMC free article] [PubMed]
44. Pyati UJ, Look AT, Hammerschmidt M. Zebrafish as a powerful vertebrate model system for in vivo studies of cell death. Semin Cancer Biol. 2007;17:154–165. [PubMed]
45. Tucker B, Lardelli M. A rapid apoptosis assay measuring relative acridine orange fluorescence in zebrafish embryos. Zebrafish. 2007;4:113–116. [PubMed]
46. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000;92:1564–1572. [PubMed]
47. Yabu T, Todoriki S, Yamashita M. Stress-induced apoptosis by heat shock, UV and gamma-ray irradiation in zebrafish embryos detected by increased caspase activity and whole-mount TUNEL staining. Fisheries Science. 2001:333–340.
48. Wang C, Ko HS, Thomas B, Tsang F, Chew KC, et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum Mol Genet. 2005;14:3885–3897. [PubMed]
49. Perez FA, Palmiter RD. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A. 2005;102:2174–2179. [PubMed]
50. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development. 2004;131:2183–2194. [PubMed]
51. Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, et al. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc Natl Acad Sci U S A. 2005;102:8024–8029. [PubMed]
52. Saini N, Oelhafen S, Hua H, Georgiev O, Schaffner W, et al. Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals enhancement of anti-oxidative pathways. Neurobiol Dis.: in press 2010 [PubMed]
53. Cha GH, Kim S, Park J, Lee E, Kim M, et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A. 2005;102:10345–10350. [PubMed]
54. Flinn L, Mortiboys H, Volkmann K, Koster RW, Ingham PW, et al. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain. 2009;132:1613–1623. [PubMed]
55. Woods IG, Schier AF. Targeted mutagenesis in zebrafish. Nat Biotechnol. 2008;26:650–651. [PMC free article] [PubMed]
56. Stemple DL. TILLING—a high-throughput harvest for functional genomics. Nat Rev Genet. 2004;5:145–150. [PubMed]
57. Moens CB, Donn TM, Wolf-Saxon ER, Ma TP. Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic. 2008;7:454–459. [PMC free article] [PubMed]
58. Schlehe JS, Lutz AK, Pilsl A, Lämmermann K, Grgur K, et al. Aberrant folding of pathogenic parkin mutants: aggregation versus degradation. J Biol Chem. 2008;283:13771–13779. [PubMed]
59. Mullins MC, Hammerschmidt M, Haffter P, Nusslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol. 1994;4:189–202. [PubMed]
60. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253–310. [PubMed]
61. Urasaki A, Morvan G, Kawakami K. Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition. Genetics. 2006;174:639–649. [PubMed]
62. Rink E, Wullimann MF. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Brain Res Dev Brain Res. 2002;137:89–100. [PubMed]
63. Westermann B, Neupert W. Mitochondria-targeted green fluorescent proteins: convenient tools for the study of organelle biogenesis in Saccharomyces cerevisiae. Yeast. 2000;16:1421–1427. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science